Circulating microRNAs as Disease Markers in Pediatric Cancers
A Feasibility Study of Circulating microRNAs as Disease Markers in Pediatric Cancers
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
A observational or N/A phase clinical study on Central Nervous System and Leukemia, this trial is completed. The trial is conducted by Ann & Robert H Lurie Children's Hospital of Chicago and has accumulated 12 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Feb 2025 — Present [monthly]
Completed
Status: Unknown → Completed
-
Sep 2024 — Feb 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Aug 2018 — Nov 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Mar 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ann & Robert H Lurie Children's Hospital of Chicago
For direct contact, visit the study record on ClinicalTrials.gov .